Many patients on long-term antihypertensive treatment consider follow-up visits unnecessary as long as their home blood pressure measurements are normal and drugs can be ordered by phone. Are follow-up visits really needed?
In patients with a viral respiratory tract infection the complete blood count (CBC) may reveal transient abnormalities. One such finding is a reduced neutrophil count, which usually does not fulfil the criteria of neutropenia but raises concerns of worsening or a more serious underlying condition. How should we interpret such results and approach such patients? What should we pay attention to?
What should be the duration of anticoagulation treatment in a patient after an episode of venous thromboembolism (VTE) with confirmed hypercoagulability? Which patients need lifelong treatment? In whom can we consider discontinuation?
How do you see the future of internal medicine in Europe? Is there a chance to unify the internal medicine curriculum in all European Union countries? Should we expect European examination and certification in internal medicine?